Testing effectiveness (Phase 2)Ended earlyNCT02885324
What this trial is testing
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain Tumor+1 more
Indiana University 4